Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

NCT00006219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: clarithromycin
DRUG: prasterone

Sponsor

Mayo Clinic

Collaborators

[object Object]